T-cell prolymphocytic leukemia classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
{{T-cell prolymphocytic leukemia}}                                                                 
{{CMG}}; {{AE}}{{Qurrat}}, {{MV}}
 
==Overview==
[[T cell|T-cell]] [[prolymphocytic leukemia]] is classified into three variants based on its [[morphology]].
 
==Classification==
[[T cell|T-cell]] [[prolymphocytic leukemia]] [[classification]] is based on its [[morphology]]. <ref name="pmid23382603">{{cite journal |vauthors=Graham RL, Cooper B, Krause JR |title=T-cell prolymphocytic leukemia |journal=Proc (Bayl Univ Med Cent) |volume=26 |issue=1 |pages=19–21 |year=2013 |pmid=23382603 |pmc=3523759 |doi= |url=}}</ref><ref name="pmid26980727">{{cite journal |vauthors=Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES |title=The 2016 revision of the World Health Organization classification of lymphoid neoplasms |journal=Blood |volume=127 |issue=20 |pages=2375–90 |date=May 2016 |pmid=26980727 |pmc=4874220 |doi=10.1182/blood-2016-01-643569 |url=}}</ref><ref name="pmid1742486">{{cite journal |vauthors=Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, Sempere A, Catovsky D |title=Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia |journal=Blood |volume=78 |issue=12 |pages=3269–74 |date=December 1991 |pmid=1742486 |doi= |url=}}</ref><ref name="pmid17369126">{{cite journal |vauthors=Foucar K |title=Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome |journal=Am. J. Clin. Pathol. |volume=127 |issue=4 |pages=496–510 |date=April 2007 |pmid=17369126 |doi=10.1309/KWJYBCCGTB90B6AE |url=}}</ref> 
*
{| align="center"
! rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Morphological Variant
! rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Percentage of total number
|-
! colspan="1" align="center" style="background:#DCDCDC;" |Typical T-cell prolymphocytic leukemia
! colspan="1" align="center" style="background:#DCDCDC;" |75 percent
|-
! colspan="1" align="center" style="background:#DCDCDC;" |Small cell variant
! colspan="1" align="center" style="background:#DCDCDC;" |20 percent
|-
! colspan="1" align="center" style="background:#DCDCDC;" |Cerebriform (Sézary cell-like) variant
! colspan="1" align="center" style="background:#DCDCDC;" |5 percent
|}


{{T-cell-prolymphocytic leukemia}}
{{T-cell-prolymphocytic leukemia}}

Latest revision as of 15:27, 3 April 2019

T-cell prolymphocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

T-cell prolymphocytic leukemia classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of T-cell prolymphocytic leukemia classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on T-cell prolymphocytic leukemia classification

CDC on T-cell prolymphocytic leukemia classification

T-cell prolymphocytic leukemia classification in the news

Blogs on T-cell prolymphocytic leukemia classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for T-cell prolymphocytic leukemia classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Maria Fernanda Villarreal, M.D. [3]

Overview

T-cell prolymphocytic leukemia is classified into three variants based on its morphology.

Classification

T-cell prolymphocytic leukemia classification is based on its morphology. [1][2][3][4]

Morphological Variant Percentage of total number
Typical T-cell prolymphocytic leukemia 75 percent
Small cell variant 20 percent
Cerebriform (Sézary cell-like) variant 5 percent

T-cell prolymphocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating T-cell Prolymphocytic Leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

T-cell prolymphocytic leukemia classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of T-cell prolymphocytic leukemia classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on T-cell prolymphocytic leukemia classification

CDC on T-cell prolymphocytic leukemia classification

T-cell prolymphocytic leukemia classification in the news

Blogs on T-cell prolymphocytic leukemia classification

Directions to Hospitals Treating T-cell prolymphocytic leukemia

Risk calculators and risk factors for T-cell prolymphocytic leukemia classification

References

  1. Graham RL, Cooper B, Krause JR (2013). "T-cell prolymphocytic leukemia". Proc (Bayl Univ Med Cent). 26 (1): 19–21. PMC 3523759. PMID 23382603.
  2. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (May 2016). "The 2016 revision of the World Health Organization classification of lymphoid neoplasms". Blood. 127 (20): 2375–90. doi:10.1182/blood-2016-01-643569. PMC 4874220. PMID 26980727.
  3. Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, Sempere A, Catovsky D (December 1991). "Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia". Blood. 78 (12): 3269–74. PMID 1742486.
  4. Foucar K (April 2007). "Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome". Am. J. Clin. Pathol. 127 (4): 496–510. doi:10.1309/KWJYBCCGTB90B6AE. PMID 17369126.

Template:WH Template:WS